Jiangsu Apon Medical Technology Co Ltd Class A

Jiangsu Apon Medical Technology Co Ltd Class A

300753 · SHE · Healthcare / Medical Instruments & Supplies

20.33CNY-0.77 (-3.65%)

Price History

Full chart

Market Stats

Previous Close21.10
Open21.24
Day Range20.11 – 21.48
52-Week Range16.91 – 44.12
Volume8.56M
Market Cap2.60B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.12
Dividend Yield0.00%
Beta0.51
50-Day Avg22.03
200-Day Avg26.69

About

Jiangsu Apon Medical Technology Co., Ltd. engages in the research and development, production, and sale of medical devices for anesthesia and analgesia, nasal airway, and chronic pain management in China. It offers pain management services, such as high-precision intelligent microcomputer infusion pumps, wireless analgesia management systems, internal heat needle therapy devices, low-frequency therapy devices, and shockwave therapy devices; and iPainfree, a wireless analgesia management system software. The company also provides nasal and upper airway management solutions, including daily nasal care, perioperative care for nasal diseases, rhinitis diagnosis and treatment, snoring diagnosis and treatment, and allergy treatment; and sleep monitoring and improvement solutions. In addition, it is involved in research and development of digital diagnostic and treatment products for neurological diseases, cognitive training, and sleep monitoring; and research, development, production, and sale of medical devices comprising brain neuromodulation and intracranial implantable electrodes. Jiangsu Apon Medical Technology Co., Ltd. was founded in 2001 and is headquartered in Nantong, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Zhi Hui Zhang
  • Employees592
  • HeadquartersEast Side of Yongtong Avenue, Nantong, China, China
  • Websitehttps://www.apon.com.cn

Leadership

  • Mr. Zhi Hui ZhangGM & Director · b. 1971
  • Mr. Dongqi YuanDeputy GM & CFO · b. 1977
  • Mr. Yu Fei YeSecretary to the Board · b. 1987
  • Mr. Haifeng YingDeputy General Manager · b. 1976
  • Yanfei ShiAccounting Supervisor

Financials

Income Statement

Currency: CNY2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue120.35M153.52M198.30M246.92M298.03M379.65M443.08M461.21M323.81M422.17M403.80M342.02M
Growth (%)-+27.56%+29.17%+24.52%+20.70%+27.38%+16.71%+4.09%-29.79%+30.38%-4.35%-15.30%
Cost of Revenue33.88M40.13M50.95M62.28M70.03M112.02M188.59M166.33M163.82M145.71M127.74M107.94M
Gross Profit86.47M113.39M147.36M184.64M228.00M267.63M254.48M294.88M159.99M276.46M276.06M234.07M
Gross Margin71.85%73.86%74.31%74.78%76.50%70.49%57.44%63.94%49.41%65.49%68.37%68.44%
Operating Expense51.68M86.05M98.24M113.95M142.44M146.90M140.95M239.09M248.31M262.50M252.58M259.96M
Operating Income34.80M27.34M49.11M70.69M85.56M120.73M113.53M55.79M-88.32M13.97M23.49M-25.89M
Operating Margin28.91%17.81%24.77%28.63%28.71%31.80%25.62%12.10%-27.28%3.31%5.82%-7.57%
EBITDA39.81M34.94M64.03M78.79M93.07M127.66M121.61M69.31M-74.48M29.55M38.50M-1.43M
EBITDA Margin33.08%22.76%32.29%31.91%31.23%33.63%27.45%15.03%-23.00%7.00%9.53%-0.42%
Net Income31.38M28.90M47.70M57.92M70.09M102.34M96.96M54.06M-75.98M8.28M10.80M-24.02M
Net Income Margin26.08%18.82%24.06%23.46%23.52%26.96%21.88%11.72%-23.46%1.96%2.67%-7.02%
R&D6.72M9.78M15.36M20.03M20.98M24.50M23.55M43.98M34.95M36.55M33.28M40.56M
R&D as % of Total Revenue5.58%6.37%7.74%8.11%7.04%6.45%5.32%9.54%10.79%8.66%8.24%11.86%
Interest Expense106.77K89.27K105.60K100.73K160.83K88.18K86.87K1.23M2.60M3.48M3.47M3.26M
Interest Expense % of Total Revenue0.09%0.06%0.05%0.04%0.05%0.02%0.02%0.27%0.80%0.83%0.86%0.95%

Balance Sheet

Currency: CNY2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets115.80M180.28M294.51M333.26M687.96M757.64M827.24M899.06M870.21M859.57M863.49M859.71M
Total Liabilities34.43M34.88M64.92M53.87M74.56M82.76M87.40M118.54M183.85M162.38M155.62M180.03M
Total Equity77.47M141.01M223.92M271.84M604.86M674.88M739.52M779.62M685.58M696.20M699.66M667.45M
Cash12.16M74.08M141.72M169.82M436.14M420.59M388.56M274.66M249.25M200.90M201.63M164.60M
Total Debt3.00M3.00M----3.73M39.86M68.37M76.42M76.72M-
Net Debt-9.16M-71.08M-141.72M-169.82M-436.14M-420.59M-384.83M-234.81M-180.88M-124.48M-124.92M-

Cash Flow

Currency: CNY2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow33.49M38.08M60.97M67.08M78.13M77.59M83.34M18.29M-24.59M-23.34M15.68M2.33M
Investing Cash Flow-9.48M3.99M-20.25M-28.43M-72.77M-57.10M-83.05M-96.73M-24.84M-27.14M-7.97M-
Financing Cash Flow-17.27M19.83M26.73M-10.40M260.71M-36.08M-32.32M-35.85M23.92M1.67M-6.97M-
Capital Expenditure2.66M3.10M4.33M15.66M61.59M58.33M35.64M39.60M24.17M30.73M10.23M8.43M
Free Cash Flow30.83M34.98M56.64M51.41M16.54M19.26M47.70M-21.32M-48.76M-54.07M5.45M-6.10M
Dividends Paid3.38M7.14M16.15M10.00M32.32M32.32M32.32M31.51M634.00K1.33M9.65M10.13M
FCF to OCF92.05%91.86%92.90%76.65%21.17%24.83%57.24%-116.56%198.28%231.69%34.77%-261.55%
Dividend Paid to FCF10.98%20.42%28.51%19.45%195.38%167.77%67.75%-147.84%-1.30%-2.46%176.98%-165.95%

Earnings

Report DateDec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023May 20, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 20, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------------
EPS Actual0.160.120.210.270.210.070.190.200.310.150.140.090.04-0.09-0.11-0.22-0.190.010.010.030.010.010.06-0.040.06-0.14-0.010.06-0.10-0.03-0.04
Surprise-------------------------------
Timing---------------------After-hours---After-hours-----

Key Statistics & Ratios

Market Cap2.60B
Enterprise Value2.69B
Trailing P/E0.00
Forward P/E0.00
Price / Sales7.85
Price / Book4.09
EPS-0.12
Book Value5.22
Revenue (TTM)331.61M
Gross Profit (TTM)228.37M
EBITDA-1.77M
Profit Margin-4.38%
Operating Margin-8.70%
Return on Equity-2.78%
Return on Assets-1.23%
Shares Outstanding126.05M
Shares Float73.60M
Beta0.51
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20251×
0.07May 29, 2025
20241×
0.07Jun 3, 2024
20211×
0.25Jun 2, 2021
20201×
0.26May 28, 2020
20191×
0.26Apr 22, 2019

Stock Splits

  • Jun 2, 20211.2:1
  • May 28, 20201.3:1